Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ClinChoice昆翎 logo — Accelerating the development and commercialization of innova...

ClinChoice昆翎

Accelerating the development and commercialization of innovative drugs and devices.

Founded 1995 China China 91 employees Series E Total: $212.00M Biotechnology, Health Care +1

General Information

Company Name ClinChoice昆翎
Founded Year 1995
Location China China
Founders / Decision Makers
Team member
Employees 91
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series E
Social

BounceWatch is an independent company data service, not affiliated with ClinChoice昆翎. To contact ClinChoice昆翎, visit clinchoice.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ClinChoice昆翎 compare?

A PDF of ClinChoice昆翎 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ClinChoice昆翎 soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ClinChoice昆翎

ClinChoice昆翎 is a biotechnology, health care, and pharmaceutical startup that aims to be a trusted partner for innovative drug research, with a vision to advance the future of clinical development globally. Established in 1995 in Tianjin, the company has experienced substantial growth through organic expansion and strategic mergers and acquisitions, resulting in a team of over 3,000 clinical R&D professionals worldwide. With a strategic presence in key cities and regions prominent in both domestic and international pharmaceutical R&D, ClinChoice昆翎 has evolved into a local clinical CRO enterprise supporting the development of innovative drug devices. The most recent funding round for ClinChoice昆翎 was a $150.00M Series E investment on 04 July 2022, in which the startup secured backing from prominent investors including Lilly Asia Ventures, Legend Capital, Apricot Capital, Sherpa Venture Capital, and Taikang Insurance Group. The company's commitment to becoming a trusted partner for the clinical research and development of innovative pharmaceutical devices underscores its potential for future growth and impact within the industry.

Business keywords: Clinical Research, Drug Development, Pharmaceutical R&D, Clinical R&D, Clinical CRO, Innovative Drug Devices, Mergers and Acquisitions, Global Expansion

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series E $150.00M 6
Lilly Asia Ventures Legend Capital Apricot Capital
Lilly Asia Ventures, Legend Capital +4
04 Jul 2022
Series D $62.00M 2
Goldman Sachs Lilly Asia Ventures
Goldman Sachs, Lilly Asia Ventures
25 Oct 2019
Series C Undisclosed 1
Goldman Sachs
Goldman Sachs
01 May 2019
Series C Undisclosed 2
DFJ Growth Lilly Asia Ventures
DFJ Growth, Lilly Asia Ventures
01 Jan 2017
Series B Undisclosed 1
Lilly Asia Ventures
Lilly Asia Ventures
01 Jan 2014
Venture Round Undisclosed 1
Tianjin Venture Capital
Tianjin Venture Capital
01 Jan 2008
Series A Undisclosed 1
DFJ Growth
DFJ Growth
01 Jan 2007

ClinChoice昆翎 Alternatives & Competitors

View All Alternatives
ClinChoice昆翎 vs
药研社 Yaoyanshe
药研社 Yaoyanshe China

药研社是专注为医疗行业提供创新型医药研发服务的CRO科技平台，以患者为中心，致力于成为医药研发生态最有...

Series D
48 employees
AI, Biotechnology
ClinChoice昆翎 vs
CervoMed
CervoMed United States

Medicines for the Brain.

Post-IPO Debt
20 employees
Health Care, Pharmaceutical
ClinChoice昆翎 vs
Medpace
Medpace United States

Accelerating Drug, Biologic and Medical Device Clinical Development

5796 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About ClinChoice昆翎

Accelerating the development and commercialization of innovative drugs and devices.
ClinChoice昆翎 was founded in 1995.
ClinChoice昆翎 is headquartered in China.
ClinChoice昆翎 operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Clinical Research, Drug Development, Pharmaceutical R&D and Clinical R&D.
ClinChoice昆翎 has approximately 91 employees.
ClinChoice昆翎 has completed 7 funding rounds, raising a total of $212.00M. The latest funding stage is Series E.
Top alternatives and competitors to ClinChoice昆翎 include 药研社 Yaoyanshe, CervoMed, Medpace, CASI Pharmaceuticals, Inc., Rakuten Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ClinChoice昆翎 and 药研社 Yaoyanshe are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ClinChoice昆翎, https://bouncewatch.com/company/clinchoice, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes